Release
📈 Stocks
Legacy Healthcare Secures FDA Breakthrough Designation for CINAINU Alopecia Drug
(2 days ago)
Legacy Healthcare gains FDA Breakthrough Therapy status for its CINAINU alopecia treatment, marking a critical regulatory advancement for the Swiss biopharmaceutical firm's…